Mini‐Catalytically Inactive Cas13X‐Derived RNA Base Editing of β‐Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury Model

Read full text Summarise with VIRAT
Authors: Wenyi Liu, Wanda Bi, Saiying Hou, Juan Du, Ling Zeng, Anqiang Zhang, Heng Zhang, Dalin Wen, Qingli Cai, Chu Gao, Ping Lin, Min Wu
+2 more Lei Li, Jianxin Jiang
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Acute lung injury (ALI) is characterized by a considerable mortality rate and currently lacks viable therapeutic strategies. Alveolar type II epithelial cells (AT2 cells) play a critical role in lung injury repair, potentially through activation of the Wnt/β‐catenin signaling cascade, which may enhance regenerative ability of lung tissue. In this study, we developed a mini‐catalytically inactive Cas13X (mini dCas13X)‐based adenosine‐to‐inosine (A‐to‐I) RNA editing approach, designated as β‐ ca tenin T41 editing to t r ea t alv e o l ar type 2 cells (CARTEL), with the objective of alleviating lung damage in ALI. We found that CARTEL proficiently performed base editing on β‐catenin, achieving a high A‐to‐I conversion rate with minimal off‐target effects. Moreover, CARTEL significantly inhibited the degradation of β‐catenin, amplified Wnt/β‐catenin signaling activation and facilitated cellular proliferation. In a murine model of lipopolysaccharide (LPS)‐induced ALI, a single adeno‐associated virus (AAV)‐mediated administration of CARTEL effectively and primarily transduced AT2 cells, resulting in attenuated lung injury, enhanced AT2 cell proliferation, and improved pulmonary function, with no detected long‐term risks. Collectively, these findings revealed that CARTEL‐mediated RNA editing represents a promising therapeutic strategy to counteract lung injury occurring in diverse settings.

Fields of Study & Subjects

CRISPR and Genetic Engineering RNA regulation and disease RNA Interference and Gene Delivery

Publication details

Journal / source
MedComm
Volume
7
Issue
4
Pages
e70716–e70716
Publication date
30 March 2026
Language
EN